HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carvedilol therapy improved left ventricular function in a patient with arrhythmogenic right ventricular cardiomyopathy.

Abstract
An asymptomatic 35 year-old man was referred to our hospital because of abnormal ECG findings. The ECG showed complete right bundle branch block and left anterior hemiblock. Echocardiography revealed a moderately enlarged right ventricle (RV) and an apical aneurysm. RV wall motion showed diffusely moderate impairment, while the systolic function of the left ventricle (LV) was slightly decreased. The ejection fractions (EF) of the RV and LV were calculated as 28.1% and 41.9% by Simpson's method using multiple cardiac computed tomography (CT) scans. A 24 hour ambulatory ECG showed only 372 single premature ventricular contractions (PVC). Cardiac catheterizaion revealed that the RV was enlarged with prominent trabeculation and decreased motion. In an electrophysiologic study, neither electrical stimulation of the RV nor electrical stimulation plus isoproterenol infusion could induce ventricular tachycardia. Pathological examination of a biopsy from the interventricular septum of the RV revealed fibrofatty change in the myocardium. Based on these results, we made a diagnosis of arrhythmogenic right ventriclular cardiomyopathy (ARVC) and administered 5 mg of carvedilol. Sixty days after the initiation of carvedilol therapy, we performed repeat cardiac CT. The EF of the LV was markedly improved from 41.9% to 62.0%, although the EF of the RV was not changed. The number of PVCs showed no change. This case suggests that carvedilol is not only useful for controlling arrhythmia but also for improving left ventriclular function in some patients with ARVC. Sympathetic overactivity is reported to cause sudden death, so carvedilol may be a first-line drug for some patients with ARVC.
AuthorsYukio Hiroi, Katsuhito Fujiu, Shuhei Komatsu, Makoto Sonoda, Yasunari Sakomura, Yasushi Imai, Yumi Oishi, Fumitaka Nakamura, Kohsuke Ajiki, Noriyuki Hayami, Yuji Murakawa, Minoru Ohno, Yasunobu Hirata, Kuni Ohtomo, Ryozo Nagai
JournalJapanese heart journal (Jpn Heart J) Vol. 45 Issue 1 Pg. 169-77 (Jan 2004) ISSN: 0021-4868 [Print] Japan
PMID14973363 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Carvedilol
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Adult
  • Arrhythmogenic Right Ventricular Dysplasia (diagnostic imaging, drug therapy, physiopathology)
  • Carbazoles (therapeutic use)
  • Carvedilol
  • Echocardiography
  • Electrocardiography
  • Humans
  • Male
  • Myocardium (pathology)
  • Propanolamines (therapeutic use)
  • Tomography, X-Ray Computed
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: